Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.90
0.00 (0.00%)
Dec 20, 2024, 1:30 PM CST

Foresee Pharmaceuticals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
714.811,010689.51871.441,145448.02
Upgrade
Short-Term Investments
-150-100125-
Upgrade
Trading Asset Securities
---297.47351.6848.16
Upgrade
Cash & Short-Term Investments
714.811,160689.511,2691,622496.17
Upgrade
Cash Growth
-50.30%68.19%-45.66%-21.76%226.86%131.50%
Upgrade
Accounts Receivable
52.7965.9116.27---
Upgrade
Other Receivables
20.6122.1810.135.7313.9713.72
Upgrade
Receivables
73.488.0926.45.7313.9713.72
Upgrade
Inventory
143.95126.8176.4124.8834.1139.72
Upgrade
Prepaid Expenses
48.8223.5622.753.99.712.64
Upgrade
Other Current Assets
125192.5--6.62-
Upgrade
Total Current Assets
1,1061,591915.061,3031,686552.25
Upgrade
Property, Plant & Equipment
232.78135.01142.3991.19110.8117.36
Upgrade
Other Intangible Assets
116.24126.81140.96155.14209.44243.95
Upgrade
Long-Term Deferred Tax Assets
1.261.231.221.11.141.2
Upgrade
Other Long-Term Assets
6.747.76104.3990.5892.0694.49
Upgrade
Total Assets
1,4631,8611,3041,6412,1001,009
Upgrade
Accounts Payable
40.512.1322.85---
Upgrade
Accrued Expenses
106.75120.7178.4761.6845.841.01
Upgrade
Short-Term Debt
250200--30.07-
Upgrade
Current Portion of Long-Term Debt
5---20.79-
Upgrade
Current Portion of Leases
12.9615.1415.5210.29.3810.06
Upgrade
Current Income Taxes Payable
9.110.424.95---
Upgrade
Current Unearned Revenue
158.58105.481.010.781.529.32
Upgrade
Other Current Liabilities
5.526.966.381.7914.033.09
Upgrade
Total Current Liabilities
588.4470.83129.1774.45121.5963.48
Upgrade
Long-Term Debt
94.17---63.24-
Upgrade
Long-Term Leases
2.3513.1225.86.456.682.53
Upgrade
Long-Term Unearned Revenue
72.62131.67237.15239.1777.6746.1
Upgrade
Long-Term Deferred Tax Liabilities
1.361.321.321.191.221.29
Upgrade
Total Liabilities
758.9616.93393.43321.26270.4113.4
Upgrade
Common Stock
1,3681,3581,1821,1791,1691,003
Upgrade
Additional Paid-In Capital
4,7144,6173,4243,3723,3192,038
Upgrade
Retained Earnings
-5,322-4,730-3,693-3,221-2,651-2,141
Upgrade
Comprehensive Income & Other
-55.96-1.49-1.54-10.21-8.06-4.58
Upgrade
Shareholders' Equity
704.11,245910.581,3201,829895.86
Upgrade
Total Liabilities & Equity
1,4631,8611,3041,6412,1001,009
Upgrade
Total Debt
364.47228.2641.3216.65130.1512.59
Upgrade
Net Cash (Debt)
350.34931.42648.191,2521,492483.59
Upgrade
Net Cash Growth
-73.21%43.70%-48.24%-16.05%208.45%125.63%
Upgrade
Net Cash Per Share
2.577.325.4910.6714.715.04
Upgrade
Filing Date Shares Outstanding
136.78135.82118.17117.94116.94100.33
Upgrade
Total Common Shares Outstanding
136.78135.82118.17117.94116.94100.33
Upgrade
Working Capital
517.571,120785.891,2291,565488.77
Upgrade
Book Value Per Share
5.159.167.7111.1915.648.93
Upgrade
Tangible Book Value
587.861,118769.621,1651,620651.9
Upgrade
Tangible Book Value Per Share
4.308.236.519.8813.856.50
Upgrade
Machinery
225.99209.45171.58136.94144.5857.45
Upgrade
Construction In Progress
0.134.920.394.41.3177.95
Upgrade
Leasehold Improvements
30.4430.447.717.717.719.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.